Introduction
Osteoporosis and associated fractures are a significant public health concern because of related mortality, morbidity, disability, and diminished quality of life 1, 2 . Although osteoporosis is often referred to as the 'silent disease' it is highly clinically relevant due to the drastically increased risk of fractures which often occur as a consequence of the condition 1, 2 . People with schizophrenia experience poorer physical health outcomes including reduced bone mineral density [3] [4] [5] [6] , with a recent systematic review establishing that people with schizophrenia are two and a half times more likely to have osteoporosis than people of similar age and sex without mental illness 7 .
There are a multitude of complex reasons why people with schizophrenia may be at increased risk of fractures. For instance, people with schizophrenia typically take antipsychotic and other psychotropic medication which is associated with antipsychotic induced hyperprolactinaemia and osteoporosis 5 and falls 8, 9 which are a leading cause of fracture due to trauma. Moreover, people with schizophrenia engage in lower levels of physical activity 10 , have reduced lower limb strength 11 and may experience high levels of pain 12 which are important risk factors for falls 13, 14 and therefore increase the risk of fracture. In addition, people with schizophrenia are at greatly increased risk of diabetes 15, 16 which is a key risk factor for fractures in the general population 17 . Some vulnerability for falling and fractures may derive from the illness itself since children who later go on to develop schizophrenia are noted to have more motor coordination difficulties than their peers 18, 19 .
Furthermore, alcohol use disorder is common in people with schizophrenia 6 and this may also increase risk of falling and subsequent fracture. Other potential risk factors that may also increase the risk of fractures include increased levels of stress hormones such as cortisol [20] [21] [22] .
It is particularly important to determine if there is a relationship between schizophrenia and fractures as research in general medicine has consistently established increased levels of mortality following fractures 23 . In addition, fractures in people with serious mental illnesses (SMI) such as schizophrenia can also lead to a deterioration of mental state 24 , higher post-operative infection A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT 5 rates, worse ambulatory rates after one year, and a risk of contralateral fractures 25 Previously, a number of meta-analyses have reported that antipsychotic medication use is associated with an increased risk of fractures in older people 8, 27 . A selective narrative review in people with schizophrenia also indicated that osteoporotic fractures may have considerable adverse effects on general health, subjective well-being, the ability to engage in healthy lifestyle behaviors, and increased healthcare costs 9 . However, to date, no systematic review or meta-analysis has specifically investigated the relationship between schizophrenia and fractures. This is warranted in order to provide a rigorous up-to-date risk profile and inform relevant policy in this area. Therefore, we conducted a systematic review and meta-analysis to investigate the association between schizophrenia and fractures.
Method
This systematic review was conducted in accordance with the Meta-analysis of Observational Studies in Epidemiology guidelines 28 and reported in accordance with the PRISMA statement 29 following a predetermined but unpublished protocol.
Inclusion and exclusion criteria
We included observational studies (prospective, retrospective or cross-sectional) that: (a) included people with a diagnosis of schizophrenia according to recognised criteria (DSM V 30 or ICD 10 31 ) together with a control group of people without a mental illness, and (b) reported the number of fractures over any period of time. We also included observational studies that reported the number of people with schizophrenia in comparative studies containing groups with and without a fracture.
If we included mixed samples (e.g. pooled sample of SMI) we attempted to extract the schizophrenia specific data. If this was not possible we contacted the authors up to two times over a one month period to obtain the schizophrenia specific data. If we received no response and the study included >80% with a diagnosis of schizophrenia we included the data. Due to the anticipated paucity of research, we collected data on any type and body site for the fracture that was confirmed through radiographs, medical note review or self-report. We did not place any language restrictions upon our searches. When we encountered studies reporting data from the same sample at different time points, we used the most recent data and/or the largest data set.
Information sources and searches
Two independent reviewers searched Academic Search Premier, MEDLINE, Psychology and Behavioral Sciences Collection, PsycINFO, SPORTDiscus, CINAHL Plus and Pubmed from inception until October 2014. We used the key words 'schizophrenia' or 'schiz*' or 'psychosis' and 'fracture*'
or 'osteoporosis'. In addition, the reference lists of all eligible articles and recent systematic reviews
on bone health in people with schizophrenia were considered 7, 9 . Primary/corresponding authors of research groups were contacted where necessary.
Study Selection
After the removal of duplicates, two independent reviewers screened the titles and abstracts of all potentially eligible articles. Both authors applied the eligibility criteria, and a list of full text articles was developed through consensus. The two reviewers then considered the full texts of these articles and the final list of included articles was reached through consensus.
Data Extraction
Two authors independently extracted data in a predetermined database. The data collected from each article included: study design, geographical location, details of schizophrenia participants (mean age, % males, diagnosis method, details of medications and chronicity of illness, and comparison group participant characteristics (mean age, % males)). We extracted data on fractures within the studies including the body site, method of acquiring the data, duration of data collection and details regarding the circumstances that contributed to fractures (e.g. falls, accidents).
Methodological quality assessment
Two authors completed methodological quality assessment of included articles using the Newcastle Ottawa Scale (NOS; 32 ). The NOS is utilized to assess the methodological quality of non-randomized trials and has acceptable validity and reliability 32 . The assessment tool focuses on three main methodological features: (1) the selection of the groups, (2) the comparability of the groups and (3) the ascertainment of the outcome of interest. Studies were given a NOS score ranging from 0-9, with a score of 5 or greater indicative of satisfactory methodological quality.
Data analysis
The results from the included studies were reported in a narrative synthesis and also a meta-analysis in accordance with the Cochrane reviewer's handbook 33 . Where possible we extracted raw data from the studies (or utilised data provided from authors upon request) regarding the number of people with and without a fracture in the schizophrenia and control groups. We then corrected for years of observation and sample size (i.e. person-years of observation) to compare the incidence rates (IR) of fractures across studies of differing time points and report this a fracture rate per 1,000 years of observation per study. We pooled the data with a random effects meta-analysis calculating the incident rate ratio (IRR) to compare the rate of fracture between the two groups 33 . In accordance with the Cochrane reviewers handbook 33 heterogeneity was assessed with the I 2 statistic and scores of 25%, 50% and 75% were classed as low, medium and high heterogeneity accordingly. We assessed publication bias with the visual inspection of a funnel plot 33 and the begg 34 and egger 35 tests. Due to the anticipated dearth of studies and the heightened risk of obtaining a spurious result, we did not conduct moderator analysis with our results 33 . All analysis was conducted with Statsdirect and is presented with 95% confidence intervals (CI).
Results

Search results and study selection
The initial search identified 423 publications. After removal of duplicates, 367 abstracts and titles were screened (Figure 1 ). At the full text review stage, 44 articles were considered and 36 were subsequently excluded with reasons, leaving 8 articles that were included in the review. Details regarding the search results including reasons for exclusion of articles are summarised in figure 1. in a group of people with and without fractures (n=549 schizophrenia; 42, 43 ). Of the included studies only 4 set out with the primary objective to investigate the relationship between schizophrenia and fractures [36] [37] [38] 42 . The summary of the groups of studies are presented in table 1 and 2 respectively.
The average age among the participants ranged from 49.9 years 36 to 75.2 years 38 . The fracture sites considered varied in each study but the hip was the most commonly investigated [36] [37] [38] 42, 43 . None of the included studies contained clear information on the possible causes of fractures such as falls or accidents. Information regarding antipsychotic medication and other risk factors for osteoporosis and fractures was sparse among the included studies. The NOS summary score for each article is presented in tables 1 and 2. All of the articles were of acceptable methodological quality with an average NOS score 6.25 (range 5-8).
Narrative results
Studies comparing the rate of fractures in people with schizophrenia and a control group
In a study among female patients with schizophrenia, Bishop et al 40 37 . The authors found that people with schizophrenia were significantly more likely to experience hip fractures (IRR 1.91, 95% CI 1.49, 2.44).
Rate of fractures per 1000 person years
There was sufficient raw data from 5 studies to calculate the rate of fractures per 1000 person years [37] [38] [39] [40] [41] . The rate of fractures per 1000 years were higher among participants with schizophrenia in 4 studies 37-40 whilst they were slightly lower in Kelly et al 41 in the adjusted analysis when the authors investigated the influence of gender they found that male and female patients were not at increased risk of experiencing hip fractures (see table 3 ).
Meta-analysis
It was possible to pool data from five studies 37-41 involving 32,593 unique participants with schizophrenia and 138,186 control participants. This established an IRR of 1.72 (95% CI = 1.24 to 2.39, I 2 =49%; n= 168,914) and is displayed in figure 2a . The funnel plot for the main analysis was broadly symmetrical (figure 2b) and the Begg-Mazumdar (Kendall's tau = 0.33 P = 0.46) and Egger bias tests (= 0.49 P = 0.44) did not indicate any publication bias. In a subgroup analysis, we removed one study 41 with very low fracture rates in both groups and found an IRR of = 1.82 (95% CI = 1.33 to 2.50, I 2 =47%, n schizophrenia=31,055, n controls=123,291).
Insert figure 2 and 2b here
A C C E P T E D M A N U S C R I P T
Discussion
General findings
To our knowledge this is the first systematic review and meta-analysis to investigate fractures in people with schizophrenia. Across the 8 eligible studies the results are unequivocal indicating that people with schizophrenia are at increased risk of fractures. Both the results from the narrative review and meta-analyses suggest that the increased risk of fracture is approximately 50-100% in people with schizophrenia compared to people without mental illness. Clearly this is of concern, especially in light of the increased mortality rate among people with schizophrenia following major fractures 37 which may be attributed to the longer hospital stays and increased adverse events that people with schizophrenia experience following fractures 26 .
The reasons for the increased risk of fractures observed in people with schizophrenia are likely to be complex and multifactorial. However, heightened levels of osteoporosis and reduced bone mass seen in this population 7 are key factors since osteoporosis is a primary risk factor for fractures 44, 45 .
Only one study 39 reported osteoporosis in both groups and they established a considerable increased risk in the patient group (34.9% v 18.4%). The results from the narrative review also implicate antipsychotic medication as being a key factor, which is not surprising given a previous meta-analysis has demonstrated an increased risk for older adults in receipt of antipsychotics 8 . In their large national database study, Sorensen et al 36 
demonstrated a clear dose response
relationship between the number of antipsychotics and fracture risk in the 4 months immediately prior to fracture. Interestingly, although antipsychotic hyperprolactinaemia has been proposed as one mechanism reducing bone mineral density and increasing fracture risk 3, 5, 46 , Sorensen et al 36 established there was a comparable increased risk of fractures for those taking prolactin raising and sparing medication. However, it should be noted the effects of antipsychotics induced hyperprolactinaemia influence on bone mineral density will accumulate over many years 5, 47 and due to the age of participants it is likely that many participants in both groups may have taken 1 st Of the modifiable risk factors, lower limb muscle strength and balance are key predictors for falls and fractures in the general literature 13 and these are known to be impaired in people with schizophrenia 48, 49 . Exercise is the most effective single intervention to prevent falls 50 interventions. This is in line with a deficit in general preventative medical care seen in this group 56, 57 .
Limitations
Despite the fact this is the first review of its kind, it is important to consider a number of limitations which are predominantly reflected by limitations in the primary data. First, due to the paucity of data and lack of information it was not possible to conduct moderator or subgroup analyses with the results. Specifically, we could not clearly investigate the influence of increasing age, different medication classes, duration of antipsychotic exposure and other important risk factors for fractures on the pooled results. However, this is partially appeased by the narrative results which included several very large age and sex matched studies adjusting for several confounders and still found an increased risk. Second, most of the studies were cross-sectional or retrospective cohort studies.
Future prospective studies are required to further understand fractures in people with schizophrenia. Third, there was heterogeneity in the reporting of fractures and in the skeletal sites considered thus precluding evaluation of site-specific fracture risk across the studies.
Future research
There are many research questions of relevance to the clinical care of people with schizophrenia that need addressing as a priority. First, there is a need to better understand the reasons why people with schizophrenia are more likely to experience fractures and in particular investigate the contributing mechanisms, with a view to developing prevention plans. Also, research investigating the care of people with schizophrenia in general hospitals following fracture is warranted to investigate: (a) how they can be rehabilitated in the best manner and avoid prolonged stays in hospital and (b) why they appear more susceptible to adverse events in the hospital but also are at increased risk of mortality thereafter 37 In most of the studies we reviewed, the outcome was a fracture in any part of the skeleton and the circumstances in which the fracture incurred were not reported. Clearly, there is an urgent need to understand this in greater detail in order to prevent fractures in this group. There is a need for future prospective studies with specific outcome definitions, based on the site and the circumstances around the fracture to elucidate the potential mechanisms for the increased fracture Investigations of mobility limitations and falls risk in people with schizophrenia should be considered since deficits in these areas are primary causes of falls and fractures in the general population 44, 45 .
Future research could also consider the prospective investigation of falls to see if this is increased in people with schizophrenia compared to the general population.
Finally, our results show the importance of including fracture outcomes in prospective studies that provide individual patient level data in order to establish the attributable risk of schizophrenia on fracture, as well as the contribution of specific risk factors, including age, gender, race, weight, smoking, physical activity behavior (e.g. complying with health recommendations or not) and psychotropic medication use (e.g. use of long term prolactin raising medication or not, the use of benzodiazepines or not, etc.). Next to this, validation of fracture prediction algorithms used in the general population, such as FRAX 58 for people with schizophrenia might be an important area of future research to identify those most at risk of fracture. A C C E P T E D M A N U S C R I P T
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